We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 147

Ranbaxy loses FDA approval for two generics

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • November 13 2014

According to a statement that Ranbaxy Laboratories Ltd. provided to the Bombay Stock Exchange Website, the U.S. Food and Drug Administration (FDA

Healthcarepharmaceutical update

  • Clyde & Co LLP
  • -
  • India
  • -
  • October 28 2014

Sometime in May 2013, the Department of Pharmaceuticals, part of the Ministry of Chemicals and Fertilizers, Govt. Of India, released a Drug Price

International Non-Proprietary Names as trademarks in India INN or out?

  • Selvam and Selvam
  • -
  • India
  • -
  • October 14 2014

International Non-Proprietary Names (INN) are globally recognized names for pharmaceutical substances or active pharmaceutical ingredients and are

Allow case-by-case patent “evergreening” of pharmaceuticals

  • Tilleke & Gibbins
  • -
  • India, Thailand
  • -
  • October 3 2014

Patents are a key form of intellectual property (IP). The term "intellectual property" contains the word "intellectual" for the reason that one

Novartis continues its successful injunction spree

  • Lakshmikumaran & Sridharan
  • -
  • India
  • -
  • September 24 2014

Novartis AG holds the patent for the drug containing the active pharmaceutical ingredients vildagliptin and vildagliptin in combination with

FDA inspection finds CGMP violations at Bangalore facility

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • June 26 2014

The U.S. Food and Drug Administration (FDA) has issued a warning letter to the president and CEO of Apotex, Inc., claiming that the agency's

Pharmaceutical healthcare update - medical devices in India

  • Clyde & Co LLP
  • -
  • India
  • -
  • June 15 2014

Medical Devices per se do not have a separate and distinct definition under India Laws. Medical devices covered under the definition of “drug” as has

EU agency will reinstate Ranbaxy’s GMP certificate

  • Shook Hardy & Bacon LLP
  • -
  • European Union, India
  • -
  • June 12 2014

The European Medicines Agency (EMA) has reportedly concluded its investigation of alleged non-compliance with good manufacturing practice (GMP) at

Draft compensation formula for clinical trial related injury proposed

  • Nishith Desai Associates
  • -
  • India
  • -
  • June 12 2014

The office of the Drugs Controller General of India ("DCGI"), India's apex drug regulator, has published a draft formula for calculating compensation

An overview of biosimilars and the biosimilar pathway in India

  • Michael Best & Friedrich LLP
  • -
  • India
  • -
  • May 21 2014

India is one of the most densely populated countries in the world. According to the World Bank (2012), 1.237 billion people live in India, accounting